These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 8866568

  • 1. Imidazoline compounds stimulate insulin release by inhibition of K(ATP) channels and interaction with the exocytotic machinery.
    Zaitsev SV, Efanov AM, Efanova IB, Larsson O, Ostenson CG, Gold G, Berggren PO, Efendić S.
    Diabetes; 1996 Nov; 45(11):1610-8. PubMed ID: 8866568
    [Abstract] [Full Text] [Related]

  • 2. Different modes of action of the imidazoline compound RX871024 in pancreatic beta-cells. Blocking of K+ channels, mobilization of Ca2+ from endoplasmic reticulum, and interaction with exocytotic machinery.
    Zaitsev SV, Efanov AM, Raap A, Efanova IB, Schloos J, Steckel-Hamann B, Larsson O, Ostenson CG, Berggren PO, Mest HJ, Efendic S.
    Ann N Y Acad Sci; 1999 Jun 21; 881():241-52. PubMed ID: 10415922
    [Abstract] [Full Text] [Related]

  • 3. Imidazolines and the pancreatic B-cell. Actions and binding sites.
    Rustenbeck I, Köpp M, Ratzka P, Leupolt L, Hasselblatt A.
    Ann N Y Acad Sci; 1999 Jun 21; 881():229-40. PubMed ID: 10415921
    [Abstract] [Full Text] [Related]

  • 4. The imidazoline RX871024 stimulates insulin secretion in pancreatic beta-cells from mice deficient in K(ATP) channel function.
    Efanov AM, Høy M, Bränström R, Zaitsev SV, Magnuson MA, Efendic S, Gromada J, Berggren PO.
    Biochem Biophys Res Commun; 2001 Jun 22; 284(4):918-22. PubMed ID: 11409880
    [Abstract] [Full Text] [Related]

  • 5. Heterogeneous characteristics of imidazoline-induced insulin secretion.
    Rustenbeck I, Leupolt L, Kowalewski R, Hasselblatt A.
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Mar 22; 359(3):235-42. PubMed ID: 10208311
    [Abstract] [Full Text] [Related]

  • 6. ATP-sensitive potassium channels and efaroxan-induced insulin release in the electrofusion-derived BRIN-BD11 beta-cell line.
    Chapman JC, McClenaghan NH, Cosgrove KE, Hashmi MN, Shepherd RM, Giesberts AN, White SJ, Ammälä C, Flatt PR, Dunne MJ.
    Diabetes; 1999 Dec 22; 48(12):2349-57. PubMed ID: 10580423
    [Abstract] [Full Text] [Related]

  • 7. Imidazoline NNC77-0074 stimulates insulin secretion and inhibits glucagon release by control of Ca(2+)-dependent exocytosis in pancreatic alpha- and beta-cells.
    Høy M, Olsen HL, Andersen HS, Bokvist K, Buschard K, Hansen J, Jacobsen P, Petersen JS, Rorsman P, Gromada J.
    Eur J Pharmacol; 2003 Apr 11; 466(1-2):213-21. PubMed ID: 12679159
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effector systems involved in the insulin secretory responses to efaroxan and RX871024 in rat islets of Langerhans.
    Mourtada M, Smith SA, Morgan NG.
    Eur J Pharmacol; 1998 Jun 05; 350(2-3):251-8. PubMed ID: 9696415
    [Abstract] [Full Text] [Related]

  • 12. Multiple effector pathways regulate the insulin secretory response to the imidazoline RX871024 in isolated rat pancreatic islets.
    Mourtada M, Chan SL, Smith SA, Morgan NG.
    Br J Pharmacol; 1999 Jul 05; 127(5):1279-87. PubMed ID: 10455276
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Imidazolines stimulate release of insulin from RIN-5AH cells independently from imidazoline I1 and I2 receptors.
    Olmos G, Kulkarni RN, Haque M, MacDermot J.
    Eur J Pharmacol; 1994 Sep 01; 262(1-2):41-8. PubMed ID: 7813577
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Threonine phosphorylations induced by RX-871024 and insulin secretagogues in betaTC6-F7 cells.
    An J, Zhao G, Churgay LM, Osborne JJ, Hale JE, Becker GW, Gold G, Stramm LE, Shi Y.
    Am J Physiol; 1999 Nov 01; 277(5):E862-9. PubMed ID: 10567013
    [Abstract] [Full Text] [Related]

  • 17. Glucose dependence of imidazoline-induced insulin secretion: different characteristics of two ATP-Sensitive K+ channel-blocking compounds.
    Bleck C, Wienbergen A, Rustenbeck I.
    Diabetes; 2004 Dec 01; 53 Suppl 3():S135-9. PubMed ID: 15561901
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Elevation of cytosolic calcium by imidazolines in mouse islets of Langerhans: implications for stimulus-response coupling of insulin release.
    Shepherd RM, Hashmi MN, Kane C, Squires PE, Dunne MJ.
    Br J Pharmacol; 1996 Nov 01; 119(5):911-6. PubMed ID: 8922740
    [Abstract] [Full Text] [Related]

  • 20. In vitro mechanism of action on insulin release of S-22068, a new putative antidiabetic compound.
    Le Brigand L, Virsolvy A, Manechez D, Godfroid JJ, Guardiola-Lemaître B, Gribble FM, Ashcroft FM, Bataille D.
    Br J Pharmacol; 1999 Nov 01; 128(5):1021-6. PubMed ID: 10556939
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.